Christodoulos Papadopoulos: Oral Anticoagulation Monotherapy in Chronic Coronary Syndrome
Christodoulos Papadopoulos, Associate Professor in Cardiology at Aristotle University of Thessaloniki, shared a post on LinkedIn about a recent article he and his colleagues co-authored, published in European Journal of Preventive Cardiology, adding:
“Our recent meta-analysis on antithrombotic strategy in CCS patients needing oral anticoagulation, nicely executed mainly by Anastasios Tsarouchas.
Major conclusion: OAC monotherapy reduces bleeding while not increasing ischemic events.
Mine interpretation: Try to limit long lasting combination therapy (more than 3 months) especially in frail patients.”
Title: Oral anticoagulant monotherapy vs. combination therapy in patients with chronic coronary syndrome: a systematic review and meta-analysis of randomized trials
Authors: Anastasios Tsarouchas, David Mutschlechner, Maximilian Tscharre, Christodoulos E Papadopoulos, Thomas Gremmel
Stay updated on all scientific advances Hemostasis Today.
-
Aug 25, 2026, 14:02Innocent Mupunga: Sri Lanka Strengthens Blood Screening Quality Through International Collaboration
-
Aug 25, 2026, 14:00Mohamed Tawengi: Balancing Bleeding and Coronary Thrombosis in STEMI With ITP
-
Aug 25, 2026, 13:55Rodrigo Assar: Modeling and Simulation to Improve Thrombosis and Hemostasis Care
-
Aug 25, 2026, 13:47Ruchi Punamia: Building Stronger Foundations in Immunohematology
-
Aug 25, 2026, 13:46Owen McCarty: How Infection Activates Coagulation Through Factor XII
-
Aug 25, 2026, 13:30Danny Hsu: AIMS 2026 to Spotlight Differential Diagnosis of Thrombotic Microangiopathy
-
Aug 25, 2026, 12:26Rahaf M. Altahan: Diagnosis and Management of Factor XIII Deficiency
-
Aug 25, 2026, 12:17Ifeanyichukwu Ifechidere: Coagulation Knowledge in Cardiology
-
Aug 25, 2026, 12:14Annie Bauzon: Platelets – The Tiny Cells That Stop You From Bleeding